Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease

Inclusion Criteria: * Adults 18 years of age or older * Must meet all AAO-HNS 2020 criteria for definite or probable Meniere's Disease * Must have a skin test positive for allergy * Is already a candidate for treatment with montelukast for allergic rhinitis/failed first line over-the-counter allergy treatments Exclusion Criteria: * Had a previous surgical procedure for treatment of vertigo * Currently receiving any allergy immunotherapy or taking montelukast or a beta-blocker * Pregnant or recent pregnancy ((≤ 8 weeks postpartum), or lactation) * Current hospitalization for any reason * Any active, acute, or chronic pulmonary disorder other than asthma * History of intubation for asthma